查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1853838

醫藥玻璃包裝市場：按容器類型、玻璃類型、最終用途、封蓋類型和分銷管道分類－2025-2032年全球預測

Pharmaceutical Glass Packaging Market by Container Type, Glass Type, End Use, Closure Type, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，醫藥玻璃包裝市場規模將成長 482 億美元，複合年成長率為 10.94%。

主要市場統計數據
基準年 2024 209.9億美元
預計年份：2025年 233.1億美元
預測年份：2032年 482億美元
複合年成長率 (%) 10.94%

從策略層面了解影響醫藥玻璃包裝的技術、監管和供應鏈動態，從而引導可執行的決策。

醫藥玻璃包裝面臨嚴格的法律規範、不斷發展的藥物劑型以及日益複雜的供應鏈的多重挑戰。過去十年，治療產品組合的變化，特別是生技藥品和注射劑的興起，推動了對包裝形式的需求，這些包裝形式優先考慮容器的完整性、可萃取/可浸出特性以及低溫運輸相容性。同時，永續性的期望和循環經濟的目標正在重塑整個價值鏈的材料選擇和採購標準。

因此，從配料商和契約製造製造商到採購團隊和監管機構，相關人員必須清晰地整合影響包裝決策的技術、商業性和地緣政治因素。本出版物概述了影響材料選擇、封蓋相互作用和分銷限制的關鍵因素，為後續分析組裝了策略背景。隨著監管審查力度加大和產品複雜性增加，務實地進行供應商資格確認、品質工程和風險緩解對於商業性成功至關重要。

以下章節將揭示產業格局的變革性轉變，深入探討近期美國關稅措施在2025年的累積影響，並提供切實可行的細分和區域洞察，以幫助產業領導者確定投資和營運調整的優先順序。過渡性說明將技術要務與商業性成果連結起來，使決策者能夠將洞察轉化為短期和中期行動。

藥物劑型演變、監管審查、供應鏈多元化和永續性措施如何重塑藥品玻璃包裝策略

隨著藥物劑型創新、監管要求不斷提高以及對永續性的承諾，醫藥玻璃包裝產業正經歷一場變革，這要求材料科學和供應鏈韌性達到更高水準。生技藥品和複雜的注射劑對容器密封系統提出了更高的要求，加速了對更高等級硼矽酸配方、先進的瓶塞化學技術以及增強型表面處理的需求，這些技術能夠減少分層並保持藥物相容性。同時，製造商也在投資分析能力，以便更好地表徵產品生命週期中的萃取物和浸出物。

供應鏈策略也在不斷演變。企業正在實現供應商多元化，並對多個區域供應商進行認證，以規避地緣政治和關稅風險；同時，企業也與玻璃製造商和瓶蓋供應商建立更深入的戰略夥伴關係，以確保優先配額並共同製定產品規格。數位化進一步強化了這種向供應商合作的轉變，可追溯性平台和智慧標籤提高了批次層級的可視性，並在必要時能夠更快地進行召回和隔離。

永續性已從聲譽考量轉變為營運重點，推動了對再生材料、節能玻璃製造和循環物流的投資。因此，採購和研發團隊正在權衡上游製程排放、報廢管道和材料替代等因素，同時兼顧技術性能標準。這些變革性動態共同要求制定整體策略，協調研發、品質、採購和監管職能，以在最佳化成本和提升韌性的同時，維持產品完整性。

分析2025年美國關稅對醫藥玻璃包裝採購經濟性、供應商合格及戰略供應鏈韌性的累積影響

2025年美國關稅的實施對整個醫藥玻璃包裝生態系統的籌資策略、供應商經濟狀況和商業談判都產生了累積影響。對於先前依賴跨境供應高品質玻璃管、玻璃容器和特殊瓶蓋的製造商而言，進口成本的上漲立即促使他們重新審視到岸成本的計算方法和合約條款。為此，採購團隊正在加快推進國內及關聯國家工廠的供應商資格認證計劃，以降低關稅造成的價格波動風險。

除了直接的成本壓力外，關稅還促使企業進行更廣泛的營運改革。各公司重新審視了庫存管理方式和安全存量基準，以平衡持有大量陸基庫存增加的成本與關稅相關中斷再次發生的風險。此外，資本配置也轉向支持雙重採購計劃，與區域玻璃製造商簽訂長期承購協議，並在條件允許的情況下投資本地加工能力。這些措施旨在縮短前置作業時間，並保護關鍵項目免受成本突然增加的影響。

從監管和合規的角度來看，對替代供應商進行資格合格需要品質、監管和供應鏈團隊之間的跨職能協作，以確保新供應商滿足既定的化學品和顆粒物規格，同時避免引入不必要的專案風險。 2025 年的關稅環境進一步凸顯了整合籌資策略的重要性，該策略應將成本控制與技術合格、營運彈性以及買賣雙方共用擔風險的合約機制相結合。

透過對容器類型、玻璃分類、治療用途、封蓋技術和分銷管道進行深度細分分析，可以做出切實可行的包裝決策。

一個完善的細分框架揭示了產品形態、材料成分、最終用途、瓶蓋設計和分銷管道如何共同影響醫藥玻璃包裝的技術要求和商業性優先級。容器類型決定了關鍵性能指標：安瓿瓶適用於單劑量應用，可最大限度減少污染；而瓶子則用於口服液和外用藥物，其首要考慮的是惰性和與給藥機制的兼容性。

玻璃類型進一步影響決策，I 型玻璃通常因其優異的耐水解性而成為高穩定性生技藥品的首選，但當加工經濟性和特定監管管道允許時，也可選用於 II 型和 III 型玻璃。生物技術產品、注射劑、眼科產品、口服製劑和疫苗等最終用途類別具有獨特的監管和功能限制，這些限制與容器和密封件的選擇、滅菌方法以及可萃取物/可浸出物測試制度相關。壓蓋可為注射劑小瓶提供可靠的無菌保證，橡膠塞可提供必要的管瓶，溴丁基橡膠和氯丁基橡膠等不同材質因其彈性體相容性和滲透性而被選用，而螺旋蓋和卡扣蓋則適用於口服和外用製劑，因為這些製劑對可重複密封性和用戶工程學要求較高。

分銷管道也影響包裝的優先考慮因素：醫院藥房需要堅固耐用的包裝，以適應高容量、無菌操作環境；線上藥房管道優先考慮安全、防篡改的解決方案以及在分銷過程中的環境穩定性；而零售藥房則必須在貨架吸引力、耐用性和易取用性之間取得平衡。整合這些細分因素，可以更細緻地了解產品規格、供應商能力和品管措施，從而確定特定玻璃瓶和瓶蓋組合是否適用於每種治療方法和分銷情況。

美洲、歐洲、中東和非洲以及亞太地區面臨的戰略挑戰，推動了採購、合規和產能擴張的優先事項。

在整個醫藥玻璃包裝價值鏈中，區域動態持續對採購、監管協調和產能擴張決策產生決定性影響。在美洲，製造商受益於接近性大型醫藥中心以及對監管合規的重視（優先考慮快速資格確認） ，但同時也面臨著本地化供應和降低關稅的壓力。這促使他們投資建立本土化改造能力並加強與供應商的夥伴關係，以確保高價值生技藥品計畫的持續性。

歐洲、中東和非洲呈現出多元化的格局，先進的玻璃製造能力與不斷變化的監管環境並存。歐洲生產商往往在低鹼硼硼矽酸和節能爐技術的創新方面處於領先地位，而該地區的法規結構則強調對可萃取物和可浸出物進行嚴格的評估，從而推動供應商儘早參與並提交詳盡的文件。同時，中東和非洲市場作為分銷中心和區域製造擴張的潛在地點，其重要性日益凸顯，以滿足不斷成長的當地需求。

亞太地區仍然是玻璃原液生產和加工的重要中心，該地區的製造商正在擴大產能以滿足全球供應鏈的需求。該地區的製造業深度和成本競爭力使其成為重要的策略供應來源，但對品質的要求和監管的協調一致要求企業持續發展供應商並建立健全的審核機制。由於產能、監管要求和地緣政治因素在任何特定地區都相互作用，企業必須制定差異化的區域策略，將在地採購與有效的全球支持相結合。

一家領先供應商如何將高純度玻璃技術、整合品質系統、策略性收購和合作夥伴關係相結合，以滿足不斷變化的製藥需求

主要企業透過投資高純度玻璃配方、整合品質系統以及拓展貿易以外的夥伴關係關係來脫穎而出。具有策略眼光的公司正採用先進的分析技術來監控生產的一致性，利用線上檢測技術來降低缺陷率，並投資低排放爐技術，以實現營運效率和永續性目標。同時，一些供應商正在拓展其服務範圍，例如提供法規文件協助、開展穩定性測試合作以及與藥物研發商共同開發契約，以加快產品上市速度並降低新型容器密封結構帶來的風險。

競爭動態也反映出某些細分領域的整合趨勢，大型製造商透過擴大產能或進行策略性收購來擴大在管瓶和預填充式注射器等高需求劑型中的規模。同時，靈活的專業供應商則專注於利基技術，例如高性能密封配方或針對特定技術故障模式的先進玻璃塗層。由此導致供應商出現兩極化，規模和專業化並存，迫使製藥公司採取以技術相容性、產能可靠性和長期創新藍圖圖為驅動的先進供應商細分策略。

最後，隨著企業尋求在實際條件下檢驗整合容器密封系統，設備製造商、彈性體製造商和分析實驗室之間的跨產業合作日益普遍。此類夥伴關係能夠縮短資格確認週期，並提高產品在上市時以及整個生命週期各個階段的效能可預測性。

為製造商提供切實可行的、可複製的措施，以增強供應商多樣性、檢驗容器密封性能，並在不損害產品完整性的前提下融入永續性。

產業領導者應採取多管齊下的方法，將技術檢驗、採購彈性和永續性性相結合，以在保持商業性靈活性的同時保障產品完整性。這首先要針對關鍵產品形式和材料實施雙重籌資策略，並建立快速供應商資格確認管道，重點關注可萃取物和可萃取物的分析可比性、容器密封完整性和顆粒物特徵。這些措施可以減少單一供應商帶來的損失，並為應對地緣政治或關稅相關干擾提供營運方案。

同時，生命週期概念應融入包裝決策，評估在符合回收性、爐能耗和藥品穩定性要求的前提下，盡可能採用再生玻璃屑。過渡計畫應分階段進行穩定性和相容性研究檢驗，以避免意外的品質風險。此外，應優先考慮與能夠提供聯合開發能力、法規文件協助以及與雙方商定的績效指標掛鉤的產能擴張承諾的供應商建立長期夥伴關係。

在營運方面，我們投資先進的測試和追溯系統，以加強批次級控制，並在出現偏差時加快根本原因分析。我們儘早讓跨職能團隊參與容器和封蓋的選擇，以確保配方科學家、品質、供應鏈和法規部門在測試方案和驗收標準方面保持一致。最後，我們持續進行動態情境規劃，模擬關稅變化、原料短缺和需求激增等情況，使領導者能夠及時做出基於事實的決策，從而在技術完整性和商業性需求之間取得平衡。

一種透明且有效的調查方法，結合專家訪談、法規和技術文獻研究以及三角驗證，為可操作的包裝情報提供支援。

本分析的調查方法結合了定性和定量證據，以得出可靠且有理有據的結論和建議。主要資訊收集工作包括對來自製造商、合約包裝商和供應商公司的包裝工程師、採購負責人、法規事務專業人員和品質保證專家進行結構化訪談，以獲取有關技術挑戰、採購動態和戰略應對措施的第一手觀點。這些訪談旨在揭示細分和區域分析所需的營運限制、供應商選擇標準和檢驗方法。

二次研究包括對監管指導文件、行業技術標準、關於玻璃配方和瓶蓋相互作用的白皮書以及近期發表的關於可萃取物/可浸出物、分層和容器密封完整性測試的同行評審文獻的全面審查。這些背景資料為比較評估提供了最佳實踐框架和技術基準。數據檢驗透過三角測量法實現。訪談中發現的論點和趨勢與已記錄的監管立場以及供應商和行業聯盟披露的生產能力資訊進行了交叉核對。

本調查方法的局限性包括關稅政策的不斷演變（可能快速變化）以及供應商在專有配方和工藝規範披露方面的差異。為彌補這些局限性，我們納入了敏感度分析和情境分析，並精心挑選受訪者，以確保其在地域、公司規模和職能角色方面的多樣性。最終形成的調查方法兼顧了深刻的洞察和實際檢驗，可為策略決策提供支援。

協調技術檢驗、供應商韌性和永續性以保障藥品品質和商業性靈活性的關鍵要點

總之，醫藥玻璃包裝正處於策略曲折點，技術要求、監管嚴格程度和供應鏈動態正在交匯融合，重塑採購和開發選擇。複雜生技藥品和注射療法的興起，凸顯了材料選擇、密封化學和容器密封完整性的重要性，因此需要更早地進行跨職能協作和供應商參與。同時，關稅波動和地緣政治格局的變化正在加速區域化和雙重採購模式的形成，迫使企業重新思考庫存策略和資格認證管道。

如今，永續性和營運效率與採購和研發決策直接相關，推動企業投資低排放氣體生產、在適當情況下使用再生材料以及循環物流。為了應對這項挑戰，企業必須將嚴謹的技術檢驗與策略性的供應鏈多元化相結合，投資於數位化可追溯性和檢測能力，並建立支持協同開發和監管環境的長期夥伴關係關係。這些努力的結合將使製藥企業和供應商能夠在日益複雜的全球環境中，在保障產品品質的同時，保持商業性靈活性和合規性。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 琥珀色管瓶擴大被用於提高生物藥品在紫外光下的穩定性。
  • 增強預填充玻璃注射器的應用，以提高生技藥品製劑給藥的劑量準確性和安全性
  • 過渡到使用 I 型硼矽酸玻璃容器，以滿足注射藥物嚴格的監管要求。
  • 增加對先進玻璃塗層技術的投資，以降低顆粒污染的風險
  • 用於疫苗儲存的內置微生物屏障的多劑量管瓶的需求激增
  • 採用在玻璃容器中嵌入RFID感測器的智慧包裝解決方案，實現藥品即時追蹤
  • 開發薄壁玻璃墨盒，以最佳化注射包裝的材料利用率並最大限度地減少碳排放
  • 擴大回收和玻璃重熔舉措，以支持永續的藥品包裝實踐

第6章美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依容器類型分類的醫藥玻璃包裝市場

  • 安瓿
  • 瓶子
    • 口服液
    • 局部的
  • 墨水匣
    • 安全
    • 標準
  • 預填充式注射器
  • 管瓶
    • 多次給藥
    • 單一劑量

9. 依玻璃類型分類的醫藥玻璃包裝市場

  • 一型
  • II 型
  • III型

10. 依最終用途分類的醫藥玻璃包裝市場

  • 生物技術產品
  • 注射藥物
  • 眼科產品
  • 口服藥物
  • 疫苗

11. 以瓶蓋類型分類的醫藥玻璃包裝市場

  • 壓蓋
  • 橡膠帽
    • 溴丁基
    • 氯丁基
  • 螺帽
  • 卡扣式帽

第12章 按分銷管道分類的醫藥玻璃包裝市場

  • 醫院藥房
  • 網路藥房
  • 零售藥房

13. 各地區醫藥玻璃包裝市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 依組別分類的醫藥玻璃包裝市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：各國醫藥玻璃包裝市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Gerresheimer AG
    • SGD Pharma SA
    • SCHOTT AG
    • Stevanato Group SpA
    • Nipro Corporation
    • Ardagh Group SA
    • Owens-Illinois, Inc.
    • Piramal Glass Limited
    • Temco Group Ltd.
    • Universal Glass Packaging, Inc.
Product Code: MRR-02026C4CAEBB

The Pharmaceutical Glass Packaging Market is projected to grow by USD 48.20 billion at a CAGR of 10.94% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 20.99 billion
Estimated Year [2025] USD 23.31 billion
Forecast Year [2032] USD 48.20 billion
CAGR (%) 10.94%

A strategic framing of technical, regulatory, and supply chain dynamics influencing pharmaceutical glass packaging that guides actionable decisions

The pharmaceutical glass packaging arena sits at the intersection of stringent regulatory oversight, evolving drug modalities, and intensifying supply chain complexity. Over the last decade, shifts in therapeutic portfolios, especially the rise of biologics and injectable therapies, have amplified demand for packaging formats that prioritize container integrity, extractable and leachable profiles, and cold chain compatibility. At the same time, sustainability expectations and circularity ambitions are reshaping material choices and procurement criteria across the value chain.

Consequently, stakeholders-from formulators and contract manufacturers to procurement teams and regulatory affairs groups-require a clear synthesis of technical, commercial, and geopolitical influences that affect packaging decisions. This introduction frames the strategic context for the subsequent analysis by outlining the primary drivers shaping material selection, closure interactions, and distribution constraints. As regulatory scrutiny tightens and product complexity increases, pragmatic approaches to supplier qualification, quality engineering, and risk mitigation become central to commercial success.

The following sections unpack transformative shifts in the landscape, delve into the cumulative impact of recent tariff actions originating in the United States during 2025, and provide actionable segmentation and regional insights that will help industry leaders prioritize investments and operational adjustments. Transitional commentary will connect technical imperatives to commercial consequences so that decision-makers can translate insight into immediate and mid-term actions.

How evolving drug modalities, regulatory scrutiny, supply chain diversification, and sustainability commitments are reshaping pharmaceutical glass packaging strategies

The pharmaceutical glass packaging landscape is undergoing a set of transformative shifts driven by innovation in drug modalities, heightened regulatory expectations, and sustainability commitments that together demand new levels of material science and supply chain resilience. Biologics and complex injectables are placing premium requirements on container closure systems, which in turn has accelerated demand for higher-grade borosilicate formulations, advanced stopper chemistries, and enhanced surface treatments that reduce delamination and maintain drug compatibility. Concurrently, manufacturers are investing in analytical capabilities to better characterize extractables and leachables across product lifecycles.

Supply chain strategies are also evolving: companies are diversifying supplier bases and qualifying multiple regional sources to hedge geopolitical risk and tariff exposure, and they are establishing deeper strategic partnerships with glassmakers and closure suppliers to secure priority allocations and co-develop specifications. This shift toward collaborative supplier relationships is reinforced by digitalization, where traceability platforms and smart tagging improve lot-level visibility and expedite recalls or quarantines when necessary.

Sustainability has moved from a reputational consideration to an operational priority, prompting investments in recycled content, energy-efficient glass production, and circular logistics. As a result, procurement and R&D teams increasingly evaluate upstream emissions, end-of-life pathways, and material substitution trade-offs in tandem with technical performance criteria. Taken together, these transformative dynamics require holistic strategies that align R&D, quality, procurement, and regulatory functions to maintain product integrity while optimizing cost and resilience.

Analysis of the cumulative effects of United States tariff actions in 2025 on sourcing economics, supplier qualification, and strategic supply chain resilience across pharmaceutical glass packaging

Tariff actions originating in the United States during 2025 have had a cumulative effect on sourcing strategies, supplier economics, and commercial negotiations across the pharmaceutical glass packaging ecosystem. For manufacturers that historically relied on cross-border supplies for high-quality tubing, primary glass containers, and specialized closures, increased import costs have prompted immediate reassessment of landed cost calculations and contract terms. In response, procurement teams have accelerated supplier qualification programs in domestic and allied-country facilities to reduce exposure to tariff-driven price volatility.

Beyond direct cost pressure, tariffs have catalyzed broader operational changes. Organizations have revisited inventory policies and safety stock levels, balancing the increased cost of holding larger onshore inventories against the risk of recurrent tariff disruption. Additionally, capital allocation has shifted to support dual-sourcing initiatives, signing long-term offtake agreements with regional glass manufacturers, and investing in local converting capacity where feasible. These measures have aimed to shorten lead times and protect critical programs from sudden cost escalations.

From a regulatory and compliance perspective, the need to qualify alternative sources has required cross-functional alignment across quality, regulatory affairs, and supply chain teams to ensure new suppliers meet established chemical and particulate specifications without introducing undue program risk. Ultimately, the tariff environment in 2025 has reinforced the importance of integrated sourcing strategies that combine cost management with technical qualification, operational agility, and contractual mechanisms that share risk between buyers and suppliers.

Deep segmentation analysis connecting container types, glass classifications, therapeutic end uses, closure technologies, and distribution channels to practical packaging decisions

A robust segmentation framework highlights how product form, material composition, end-use application, closure design, and distribution pathway each shape technical requirements and commercial priorities for pharmaceutical glass packaging. Container type drives primary performance criteria: ampoules are selected for single-dose, contamination-minimizing applications; bottles serve oral liquid and topical formulations and therefore emphasize inertness and compatibility with dosing mechanisms; cartridges are specified in safety and standard variants depending on device interfacing and pressure tolerances; prefilled syringes prioritize precision filling and delivery performance; and vials are produced for either multi-dose or single-dose use, with multi-dose containers requiring particular attention to stopper chemistry and preservative interactions.

Glass type further informs decision-making, with Type I formulations typically favored for high-stability biologics due to superior hydrolytic resistance, while Type II and Type III glass may be specified where processing economics or specific regulatory pathways allow. End use categories such as biotech products, injectable drugs, ophthalmic products, oral drugs, and vaccines impose unique regulatory and functional constraints that cascade into container and closure selection, sterilization approaches, and extractables/leachables testing regimes. Closure type intersects with container choice to govern container closure integrity and compatibility: crimp caps offer established sterility assurance for parenteral vials, rubber stoppers provide essential sealing functions with variants like bromobutyl and chlorobutyl chosen based on elastomeric compatibility and permeability profiles, screw caps and snap caps serve oral and topical formats where resealability and user ergonomics matter.

Distribution channels also shape packaging priorities; hospital pharmacies demand robustness for high-volume, sterile handling environments, online pharmacy channels emphasize secure tamper-evident solutions and ambient stability during logistics, and retail pharmacy formats must balance shelf appeal with durability and ease of dispensing. Integrating these segmentation dimensions enables a nuanced view of product specifications, supplier capabilities, and quality control measures that together determine the suitability of particular glass and closure combinations for each therapeutic and distribution context.

Regional strategic imperatives across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine sourcing, compliance, and capacity expansion priorities

Regional dynamics continue to exert a decisive influence on sourcing, regulatory alignment, and capacity expansion decisions across the pharmaceutical glass packaging value chain. In the Americas, manufacturers benefit from proximity to large pharmaceutical hubs and an emphasis on regulatory compliance that prioritizes rapid qualification, but they also face pressures to localize supply and reduce tariff exposure. This has encouraged investments in onshore converting capacity and deeper supplier partnerships to ensure continuity for high-value biologic programs.

Europe, Middle East & Africa present a heterogeneous landscape where advanced glass manufacturing capacities coexist with evolving regulatory harmonization efforts. European producers are often at the forefront of innovation in low-alkali borosilicate and energy-efficient furnace technologies, and regional regulatory frameworks emphasize stringent extractables and leachables evaluation, driving early supplier engagement and rigorous documentation practices. Meanwhile, markets in the Middle East and Africa are increasingly important as distribution nodes and as potential sites for regional manufacturing expansions that address local demand growth.

Asia-Pacific remains a major locus for both primary glass production and converting activities, with manufacturers in the region scaling capacity to serve global supply chains. The region's manufacturing depth and cost competitiveness make it a key strategic source, but quality expectations and regulatory alignment require sustained supplier development and robust auditing programs. Across all regions, the interplay of capacity, regulatory expectations, and geopolitical considerations requires companies to develop differentiated regional strategies that blend local sourcing with validated global backstops.

How leading suppliers combine high-purity glass technologies, integrated quality systems, strategic acquisitions, and collaborative partnerships to meet evolving pharmaceutical needs

Leading companies in the pharmaceutical glass packaging space are distinguishing themselves through investments in high-purity glass formulations, integrated quality systems, and collaborative partnerships that extend beyond transactional supply. Strategic players are deploying advanced analytics to monitor production consistency, leveraging in-line inspection technologies to reduce defect rates, and investing in low-emissions furnace technologies to address both operational efficiency and sustainability goals. In parallel, some suppliers are expanding their service offerings to include regulatory dossier support, stability testing collaborations, and joint development agreements with drug developers to accelerate time-to-market and to de-risk novel container closure configurations.

Competitive dynamics also reflect consolidation in certain segments, with larger manufacturers pursuing capacity expansions and strategic acquisitions to secure scale for high-demand formats such as vials and prefilled syringes. At the same time, nimble specialty firms focus on niche capabilities-such as high-performance stopper formulations or advanced glass coatings-that address specific technical failure modes. The result is a bifurcated supplier landscape where scale and specialization coexist, compelling pharmaceutical companies to adopt sophisticated supplier segmentation strategies based on technical fit, capacity reliability, and long-term innovation roadmaps.

Finally, cross-sector collaboration with device manufacturers, elastomer producers, and analytical laboratories has become more prevalent as companies seek to validate integrated container closure systems under real-world use conditions. Such partnerships reduce qualification timelines and improve the predictability of product performance across launch and lifecycle phases.

Practical and replicable actions for manufacturers to strengthen supplier diversification, validate container closure performance, and integrate sustainability without compromising product integrity

Industry leaders should adopt a multi-pronged approach that aligns technical validation, sourcing resilience, and sustainability to protect product integrity while maintaining commercial flexibility. Begin by instituting dual-sourcing strategies for critical formats and materials, paired with expedited supplier qualification pathways that emphasize analytical comparability for extractables and leachables, container closure integrity, and particulate profiles. These measures reduce single-source exposure and provide operational options when geopolitical or tariff-related disruptions occur.

Concurrently, integrate lifecycle thinking into packaging decisions by assessing recyclability, furnace energy intensity, and opportunities to incorporate recycled cullet where compatible with drug stability requirements. Transition plans should be phased and validated through stability and compatibility studies to avoid unintended quality risks. Moreover, prioritize long-term partnerships with suppliers that offer co-development capabilities, regulatory dossier support, and capacity expansion commitments tied to mutually agreed performance metrics.

Operationally, invest in advanced inspection and traceability systems to enhance lot-level control and to expedite root-cause analyses when deviations occur. Engage cross-functional teams early in container and closure selection to ensure that formulation scientists, quality, supply chain, and regulatory functions align on test protocols and acceptance criteria. Finally, maintain a dynamic scenario planning cadence that models tariff shifts, raw material shortages, and demand surges so leaders can make timely, evidence-based decisions that balance technical integrity and commercial imperatives.

A transparent and validated research methodology combining expert interviews, regulatory and technical literature review, and triangulation to underpin actionable packaging intelligence

The research methodology underpinning this analysis combines qualitative and quantitative evidence streams to ensure robust, defensible conclusions and actionable recommendations. Primary data collection included structured interviews with packaging engineers, procurement leaders, regulatory affairs professionals, and quality assurance experts across manufacturers, contract packagers, and supplier firms to capture first-hand perspectives on technical challenges, sourcing dynamics, and strategic responses. These interviews were designed to surface operational constraints, supplier selection criteria, and validation practices that informed the segmentation and regional analysis.

Secondary research involved a comprehensive review of regulatory guidance documents, industry technical standards, white papers on glass formulation and closure interactions, and recent peer-reviewed literature addressing extractables and leachables, delamination, and container closure integrity testing. This background informed best-practice frameworks and provided technical baselines for comparative assessment. Data validation was performed through triangulation: claims and trends identified in interviews were cross-checked against documented regulatory positions and manufacturing capability disclosures from suppliers and industry consortia.

Limitations of the methodology include the evolving nature of tariff policies, which can change rapidly, and the variability of supplier-level disclosures on proprietary formulations and process specifications. To mitigate these limitations, sensitivity analyses and scenario-based considerations were incorporated, and respondents were selected to ensure diversity across geographies, company sizes, and functional roles. The resulting methodological approach balances depth of insight with practical validation to support strategic decision-making.

Key takeaways on aligning technical validation, supplier resilience, and sustainability to protect pharmaceutical product quality and commercial agility

In conclusion, pharmaceutical glass packaging is at a strategic inflection point where technical requirements, regulatory rigor, and supply chain dynamics converge to reshape procurement and development choices. The rise of complex biologics and injectable therapies elevates the importance of material selection, closure chemistry, and container closure integrity, necessitating earlier cross-functional alignment and deeper supplier engagement. Concurrently, tariff disruptions and geopolitical shifts have accelerated regionalization and dual-sourcing approaches, prompting organizations to rethink inventory policies and qualification pathways.

Sustainability and operational efficiency now factor directly into procurement and R&D decisions, driving investments in low-emission production, recycled content where appropriate, and circular logistics. To navigate this landscape, companies must combine disciplined technical validation with strategic supply diversification, invest in digital traceability and inspection capabilities, and cultivate long-term partnerships that support co-development and regulatory readiness. These combined efforts will enable pharmaceutical manufacturers and suppliers to protect product quality while maintaining commercial agility and regulatory compliance in an increasingly complex global environment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of amber glass vials to enhance biologic drug stability under UV exposure
  • 5.2. Increasing integration of prefillable glass syringes for improved dosing accuracy and safety in biologics delivery
  • 5.3. Shift towards Type I borosilicate glass containers to meet stringent regulatory requirements for injectable drugs
  • 5.4. Growing investment in advanced glass coating technologies to reduce particulate contamination risks
  • 5.5. Surging demand for multi-dose glass vials with integrated microbial barriers for vaccine storage
  • 5.6. Adoption of smart packaging solutions embedding RFID sensors in glass containers for real-time drug tracking
  • 5.7. Development of thin-walled glass cartridges to optimize material usage and minimize carbon footprint in injectable packaging
  • 5.8. Expansion of recycling and glass remelt initiatives to support sustainable pharmaceutical packaging practices

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pharmaceutical Glass Packaging Market, by Container Type

  • 8.1. Ampoules
  • 8.2. Bottles
    • 8.2.1. Oral Liquid
    • 8.2.2. Topical
  • 8.3. Cartridges
    • 8.3.1. Safety
    • 8.3.2. Standard
  • 8.4. Prefilled Syringe
  • 8.5. Vials
    • 8.5.1. Multi Dose
    • 8.5.2. Single Dose

9. Pharmaceutical Glass Packaging Market, by Glass Type

  • 9.1. Type I
  • 9.2. Type II
  • 9.3. Type III

10. Pharmaceutical Glass Packaging Market, by End Use

  • 10.1. Biotech Products
  • 10.2. Injectable Drugs
  • 10.3. Ophthalmic Products
  • 10.4. Oral Drugs
  • 10.5. Vaccines

11. Pharmaceutical Glass Packaging Market, by Closure Type

  • 11.1. Crimp Cap
  • 11.2. Rubber Stopper
    • 11.2.1. Bromobutyl
    • 11.2.2. Chlorobutyl
  • 11.3. Screw Cap
  • 11.4. Snap Cap

12. Pharmaceutical Glass Packaging Market, by Distribution Channel

  • 12.1. Hospital Pharmacy
  • 12.2. Online Pharmacy
  • 12.3. Retail Pharmacy

13. Pharmaceutical Glass Packaging Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Pharmaceutical Glass Packaging Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Pharmaceutical Glass Packaging Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Gerresheimer AG
    • 16.3.2. SGD Pharma S.A.
    • 16.3.3. SCHOTT AG
    • 16.3.4. Stevanato Group S.p.A.
    • 16.3.5. Nipro Corporation
    • 16.3.6. Ardagh Group S.A.
    • 16.3.7. Owens-Illinois, Inc.
    • 16.3.8. Piramal Glass Limited
    • 16.3.9. Temco Group Ltd.
    • 16.3.10. Universal Glass Packaging, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY GLASS TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY GLASS TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY END USE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY END USE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. PHARMACEUTICAL GLASS PACKAGING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. PHARMACEUTICAL GLASS PACKAGING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL GLASS PACKAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY AMPOULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY AMPOULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY AMPOULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY AMPOULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY AMPOULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY AMPOULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ORAL LIQUID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ORAL LIQUID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ORAL LIQUID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ORAL LIQUID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ORAL LIQUID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ORAL LIQUID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TOPICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TOPICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TOPICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SAFETY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SAFETY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SAFETY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SAFETY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SAFETY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SAFETY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY STANDARD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY STANDARD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY STANDARD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY STANDARD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY STANDARD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY STANDARD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY PREFILLED SYRINGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY PREFILLED SYRINGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY PREFILLED SYRINGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY PREFILLED SYRINGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY MULTI DOSE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY MULTI DOSE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY MULTI DOSE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY MULTI DOSE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY MULTI DOSE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SINGLE DOSE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SINGLE DOSE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SINGLE DOSE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SINGLE DOSE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SINGLE DOSE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY GLASS TYPE, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY GLASS TYPE, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE I, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE I, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE I, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE I, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE I, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE I, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE II, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE II, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE II, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE II, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE II, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE II, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE III, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE III, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE III, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE III, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE III, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE III, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BIOTECH PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BIOTECH PRODUCTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BIOTECH PRODUCTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BIOTECH PRODUCTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BIOTECH PRODUCTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BIOTECH PRODUCTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY INJECTABLE DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY INJECTABLE DRUGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY INJECTABLE DRUGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY INJECTABLE DRUGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY INJECTABLE DRUGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY INJECTABLE DRUGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY OPHTHALMIC PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY OPHTHALMIC PRODUCTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY OPHTHALMIC PRODUCTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY OPHTHALMIC PRODUCTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY OPHTHALMIC PRODUCTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY OPHTHALMIC PRODUCTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ORAL DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ORAL DRUGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ORAL DRUGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ORAL DRUGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ORAL DRUGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ORAL DRUGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VACCINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VACCINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VACCINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VACCINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CRIMP CAP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CRIMP CAP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CRIMP CAP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CRIMP CAP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CRIMP CAP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CRIMP CAP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BROMOBUTYL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BROMOBUTYL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BROMOBUTYL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BROMOBUTYL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BROMOBUTYL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BROMOBUTYL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CHLOROBUTYL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CHLOROBUTYL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CHLOROBUTYL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CHLOROBUTYL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CHLOROBUTYL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CHLOROBUTYL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SCREW CAP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SCREW CAP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SCREW CAP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SCREW CAP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SCREW CAP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SCREW CAP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SNAP CAP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SNAP CAP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SNAP CAP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SNAP CAP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SNAP CAP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SNAP CAP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY GLASS TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY GLASS TYPE, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY GLASS TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY GLASS TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, 2018-2024 (USD MILLION)
  • TABLE 238. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY GLASS TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY GLASS TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY GLASS TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY GLASS TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY GLASS TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY GLASS TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. MIDDLE EAST PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. MIDDLE EAST PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, 2018-2024 (USD MILLION)
  • TABLE 298. MIDDLE EAST PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, 2025-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST PHARMACEUTICAL GLASS PACKAGING MAR